a leap forward, page-5

Hi Al1 and silentP,

great find Al1 and both of you guys are on the ball imho and for us Biota shareholders this will mean even more value being unlocked with Inavir.

The Japanese are tough in bussines and I am sure as I have said many times before that DS will extract as much value out of Inavir as possible.

The have achieved in their own country so fas outstanding sales with an excellent price attached to it, and having tasted the tremendous potential income from Inavir as a world leading product, will not want to give it away to some big Pharma.

At least not for a bargain, so they may even keep it to themselves or use an agency for distribution.

The USA always insists to have medicines which are of strategic and national importance to be produced in their own country, hence the production and manifacturing facility purchased by DSS.

How much further we are seeing Inavir staying with DSS/Biota is a good question , but they may still go it all the way themselves imho.

good luck and we will see a tremendous amount of value being unlocked at which the Mcap of $270 Million from Biota looks like a joke.

great find guys,

Keep up the good work

jojo